1-3 of 3
A. Charbonnier
Close
Sort by
Journal Articles

Bortezomib + Low Dose Cytarabine in Int-2 and High Risk MDS. Interim Results of a Phase I/II Trial by the GFM.

Shanti Natarajan, Pierre Fenaux, Norbert Vey, A. Guerci, I. Coulibaly, A. Charbonnier, C. Ravoet, S. Courby, G. Etienne, M.P. Chaury, S. Cheze, A. Stamatoullas, L. Legros, E. Berger, A. Lescoute, S. Vaultier, F. Dreyfus
Journal: Blood
Blood (2007) 110 (11): 1453.
https://doi.org/10.1182/blood.V110.11.1453.1453
Published: 2007
Journal Articles

Sustained Effect of First Line Sequential Therapy with Intensive Consolidation Chemotherapy and Allogeneic Hematopoietic Stem Cell Transplantation (ASCT) after Reduced Intensity Conditioning (RIC) for Patients with Acute Myeloblastic Leukemia (AML) in First Complete Remission (CR1).

Didier Blaise, MD, R. Tabrizi, MD, C. Faucher, MD, Mohamad Mohty, MD, J.O. Bay, MD, J.M. Boiron, MD, G. Marit, MD, S. Furst, MD, A.M. Stoppa, MD, A. Charbonnier, MD, T. Prebet, MD, C. Chabannon, MD, N. Vey
Journal: Blood
Blood (2006) 108 (11): 3000.
https://doi.org/10.1182/blood.V108.11.3000.3000
Published: 2006
Journal Articles

Stem Cell Transplantation in 281 Patients over 60 Years in Onco Hematologic Malignancies: A Single Center Experience.

Anne-Marie Stoppa, MD, N. Vey, MD, C. Faucher, MD, R. Bouabdallah, MD, F. Viret, MD, C. Chabannon, MDPhD, P. Ladaique, MD, D. Coso, MD, A. Charbonnier, MDPhD, J.M. Schiano, MD, P. Viens, MD, J.A. Gastaut, MD, D. Maraninchi, MD, D. Blaise, MD
Journal: Blood
Blood (2004) 104 (11): 5229.
https://doi.org/10.1182/blood.V104.11.5229.5229
Published: 2004